Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2

被引:106
|
作者
Miller, JD
Weber, DA
Ibegbu, C
Pohl, J
Altman, JD
Jensen, PE
机构
[1] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Emory Vaccine Res Ctr, Atlanta, GA 30322 USA
[3] Emory Univ, Sch Med, Microchem Facil, Atlanta, GA 30322 USA
来源
JOURNAL OF IMMUNOLOGY | 2003年 / 171卷 / 03期
关键词
D O I
10.4049/jimmunol.171.3.1369
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The MHC class Ib molecule HLA-E is the primary ligand for CD94/NKG2A-inhibitory receptors expressed on NK cells, and there is also evidence for TCR-mediated recognition of this molecule. HLA-E preferentially assembles with a homologous set of peptides derived from the leader sequence of class la molecules, but its capacity to bind and present other peptides remains to be fully explored. The peptide-binding motif of HLA-E was investigated by folding HLA-E in vitro in the presence of peptide libraries derived from a nonameric leader peptide sequence randomized at individual anchor positions. A high degree of selectivity was observed at four of five total anchor positions, with preference for amino acids present in HLA-E-binding peptides from class la leader sequences. Selectivity was also observed at the nonanchor P5 position, with preference for positively charged amino acids, suggesting that electrostatic interactions involving the P5 side chain may facilitate assembly of HLA-E peptide complexes. The observed HLA-E peptide-binding motif was strikingly similar to that previously identified for the murine class lb molecule, Qa-1. Experiments with HLA-E tetramers bearing peptides substituted at nonanchor positions demonstrated that P5 and P8 are primary contact residues for interaction with CD94/NKG2 receptors. A conservative replacement of Arg for Lys at P5 completely abrogated binding to CD94/NKG2. Despite conservation of peptide-binding specificity in HLA-E and Qa-1, cross-species tetramer-staining experiments demonstrated that the interaction surfaces on CD94/NKG2 and the class Ib ligands have diverged between primates and rodents.
引用
收藏
页码:1369 / 1375
页数:7
相关论文
共 50 条
  • [41] HLA-E and HLA-G expression on porcine endothelial cells inhibit xenoreactive human NK cells through CD94/NKG2-dependent and -independent pathways
    Sasaki, H
    Xu, XC
    Mohanakumar, T
    JOURNAL OF IMMUNOLOGY, 1999, 163 (11): : 6301 - 6305
  • [42] The HLA-G*0105N null allele induces cell surface expression of HLA-E molecule and promotes CD94/NKG2A-mediated recognition in JAR choriocarcinoma cell line
    Frédéric G. Sala
    Pierre-Marie Del Moral
    Nathalie Pizzato
    Florence Legrand-Abravanel
    Philippe Le Bouteiller
    Françoise Lenfant
    Immunogenetics, 2004, 56 : 617 - 624
  • [43] The HLA-G*0105N null allele induces cell surface expression of HLA-E molecule and promotes CD94/NKG2A-mediated recognition in JAR choriocarcinoma cell line
    Sala, FG
    Del Moral, PM
    Pizzato, N
    Legrand-Abravanel, F
    Le Bouteiller, P
    Lenfant, F
    IMMUNOGENETICS, 2004, 56 (09) : 617 - 624
  • [44] Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
    Borrego, F
    Ulbrecht, M
    Weiss, EH
    Coligan, JE
    Brooks, AG
    JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (05): : 813 - 818
  • [45] Mitogen-activated protein kinase activity is involved in effector functions triggered by the CD94/NKG2-C NK receptor specific for HLA-E
    Carretero, M
    Llano, M
    Navarro, F
    Bellón, T
    López-Botet, M
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2000, 30 (10) : 2842 - 2848
  • [46] What a Difference an Amino Acid Makes: An All-Atom Simulation Study of Nonameric Peptides in Inhibitory HLA-E/NKG2A/CD94 Immune Complexes
    Prasnikar, Eva
    Perdih, Andrej
    Borisek, Jure
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [47] CD94/NKG2A+ tumor-infiltrating lymphocytes in a context of HLA-E overexpression could be a promising new druggable inhibitory immune checkpoint in colorectal adenocarcinomas
    Eugene, Juliette
    Jouand, Nicolas
    Dansette, Delphine
    Meurette, Guillaume
    Podevin, Juliette
    Matysiak, Tamara
    Bezieau, Stephane
    Volteau, Christelle
    Thomas, Wassila El Alami
    Chetritt, Jerome
    Kerdraon, Olivier
    Fourquier, Pierre
    Thibaudeau, Emilie
    Dumont, Frederic
    Mosnier, Jean-Francois
    Toquet, Claire
    Jarry, Anne
    Gervois, Nadine
    Bossard, Celine
    CANCER RESEARCH, 2018, 78 (13)
  • [48] HLA-E upregulation on IFN-γ-activated AML blasts impairs CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT
    S Nguyen
    V Beziat
    N Dhedin
    M Kuentz
    J P Vernant
    P Debre
    V Vieillard
    Bone Marrow Transplantation, 2009, 43 : 693 - 699
  • [49] HLA-E upregulation on IFN-γ-activated AML blasts impairs CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT
    Nguyen, S.
    Beziat, V.
    Dhedin, N.
    Kuentz, M.
    Vernant, J. P.
    Debre, P.
    Vieillard, V.
    BONE MARROW TRANSPLANTATION, 2009, 43 (09) : 693 - 699
  • [50] RESIDUES OUTSIDE OF THE HLA-A2 PEPTIDE-BINDING GROOVE CAN ABROGATE OR ENHANCE RECOGNITION OF INFLUENZA-VIRUS MATRIX PEPTIDE PULSED CELLS BY CYTOTOXIC T-LYMPHOCYTES
    TENG, JMC
    HOGAN, KT
    MOLECULAR IMMUNOLOGY, 1994, 31 (06) : 445 - 457